FDA
FreeStyle Libre CGM Cleared for Use During Imaging Tests
FDA Clears Two New Abbott Over-the-Counter CGMs
Zepbound (Tirzepatide) for Chronic Weight Management: Uses, Side Effects, and Cost
FDA Warns Against Compounded Semaglutide for Diabetes, Weight Loss
FDA Surprises Novo Nordisk by Not Approving Once-Weekly Insulin
FDA Clears twiist Automated Insulin Delivery System
The twiist AID system is the first insulin pump to integrate with Tidepool Loop. Approved for people with type 1 diabetes ages 6 and up, the twiist AID system with Tidepool Loop offers precise microdosing, the option to set a target as low as 87 mg/dL, and bolusing based on different food types.